Eric Lefkofsky is a well-established and successful businessman based in the United States and has a net worth of nearly $2.2 billion. He is a serial entrepreneur and has started many small and large businesses over a period, which includes Groupon, which is one of the most successful business ventures by Eric Lefkofsky and is currently valued at over $2 billion. Eric Lefkofsky is associated with many other sectors as well including medical technology, finance and investment, technology, and more. Eric Lefkofsky is also amongst the wealthiest philanthropists in the world and runs a family foundation by the name of Lefkofsky Family Foundation that supports many high impact social and community welfare initiatives, including for education, medical, social welfare, women empowerment, art and culture, and more.
Some of the companies co-owned by Eric Lefkofsky include Echo Global Logistics, InnerWorkings, Tempus, Groupon, MediaOcean, and Lightbank. The Lefkofsky Family Foundation started by Eric Lefkofsky aims to reach out to people in need across the globe and help disadvantaged people gain access to better education, health, and high impact social initiatives. Currently, Eric Lefkofksky is busy in expanding Tempus, which is a technology, based enterprise that collects molecular and clinical data from different medical facilities to help the physicians to decide upon the treatment course in a more precise manner. Such clinical data can help the doctors to decipher what treatment would be active on the patient, and which treatment method would be more useful in comparison to other treatment options available.
For long, the doctors have been working with lack of clinical and molecular data, which have forced them to approach every disease in a one-size-fits-all approach. However, as the genetic makeup of every individual is different, some medicines are effective on some people while being ineffective on others. It is to solve this puzzle that Eric Lefkofsky created Tempus. Eric Lefkofsky has pledged to invest $100 million in Tempus, and many other private venture capital firms have also agreed to invest in this initiative. It is expected to change the way cancer treatment is provided in the future entirely. Eric Lefkofsky believes that such aggregation of medical data is essential for the doctors to provide more accurate and efficient data.